Novartis AG is 250.8x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($283.13 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COLL | NVS |
|---|---|---|
| Market cap | $1.13 B | $283.13 B |
| US-listed rank | #2551 | #47 |
| Revenue (latest FY) | $780.57M | - |
| Net income (latest FY) | $63.00M | - |
| Net margin | 8.1% | - |
| P/E (trailing FY) | 17.9 | - |
| SEC filings | 849 | 947 |
Novartis AG is 250.8x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($283.13 B vs $1.13 B).
Full pages: COLLEGIUM PHARMACEUTICAL, INC and Novartis AG, or browse the full rankings.